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1. INTRODUCTION {#cam41656-sec-0001}
===============

Suicide is one of major causes of non‐cancer‐related death, which took up 1.4% of all deaths worldwide in 2015.[1](#cam41656-bib-0001){ref-type="ref"} Several studies have also demonstrated that the suicide rate of cancer patients is twice that of general population.[2](#cam41656-bib-0002){ref-type="ref"}, [3](#cam41656-bib-0003){ref-type="ref"}, [4](#cam41656-bib-0004){ref-type="ref"}, [5](#cam41656-bib-0005){ref-type="ref"}, [6](#cam41656-bib-0006){ref-type="ref"} Notably, when considering different anatomic cancer sites, patients diagnosed with lung cancer had a higher suicide rate than those with other cancer, with a standardized mortality ratio of 5.74.[2](#cam41656-bib-0002){ref-type="ref"} Factors associated with increased suicide risk among lung cancer patients were Asians, men, older, widowed, small cell lung carcinoma, metastatic, and refusing treatment.[7](#cam41656-bib-0007){ref-type="ref"}

Lung cancer is second most common cancer, and 85% of them are non‐small cell lung carcinoma (NSCLC).[8](#cam41656-bib-0008){ref-type="ref"} Although several researchers have observed a high risk of suicide among lung cancer patients (being discussed as a single cancer entity), further examinations of patients with the most common subtype of lung cancer (NSCLC) are required, because of totally different distribution, treatment strategy and prognosis between subtypes.[2](#cam41656-bib-0002){ref-type="ref"}, [7](#cam41656-bib-0007){ref-type="ref"}, [9](#cam41656-bib-0009){ref-type="ref"} However, to our knowledge, a comprehensive study about the suicide issues among NSCLC patients has not been specifically published. Given that potential suicide prevention, knowing the trend of suicide rate and the high‐risk patient is of great importance. Therefore, we conducted this study using a large population‐based database to estimate the trend of suicide rate and identify the high‐risk group of NSCLC patients. In addition, we also performed a sub‐analysis of patients diagnosed from 2004 to 2013 to depict recent issues.

2. MATERIAL AND METHODS {#cam41656-sec-0002}
=======================

National Cancer Institute\'s Surveillance, Epidemiology, and End Results (SEER) database is an authoritative source of information on cancer incidence and survival in the United States. SEER database encompasses about 28% of United State population and collect cases diagnosed between 1973 and 2013.

We extracted data of patients diagnosed with primary NSCLC from SEER database(1973‐2013) using the SEER\*Stat software (v8.3.4, Cancer Statistic Branch, NCI, Calverton), using International Classification of Disease for Oncology, Third Edition (ICD‐O‐3), morphology codes: 8012/3, 8046/3, 8070/3, 8140/3, 8240/3, 8250/3, 8560/3 and 9053/3; and site codes: C33.9, C34.0, C34.1, C34.2, C34.3, C34.8 and C34.9.[10](#cam41656-bib-0010){ref-type="ref"}, [11](#cam41656-bib-0011){ref-type="ref"} Patients with unknown follow‐up, diagnosed below 18 and recognized by autopsy and death certificate were excluded.

Patients whose cause of death variable coded as "Suicide and self‐inflicted injury" were identified. We obtained the demographic and clinicopathological data from the SEER database, including age, sex, race, marital status, year at diagnosis, state, tumor site, grade, histologic type, stage, surgery, cause of death, survival time, vital status and radiation. Patients were divided into 3 groups according to age at diagnosis (younger than 60 years, 60‐74 years, and older than 75 years). Race were sorted by white, black and others. We classified patients as married or unmarried. Year of diagnosis were separated into 3 groups (before 1993, 1994‐2003, after 2004). We classified the tumor site as upper lung, middle lung, lower lung, and bronchus/others. Grade of tumor were categorized into I/II, III/IV, and unknown groups. Surgery and radiation were both classified as performed, not performed, and unknown. Disease stage for the analysis was coded based on the variable "SEER Historic Stage A." We give a value of 0.5 months to those who didn\'t survive for a full month after diagnosis, because SEER record their survival time in months.

Univariate analysis using chi‐square test was used to compare patients committed suicide with those died from other causes. Multivariable logistic regression was employed to find out independent risk factors for suicide. All statistical analyses were performed using R version 3.4.2 software (Institute for Statistics and Mathematics, Vienna, Austria; <http://www.r-project.org>). Statistical significance was set at two‐sided *P *\<* *.05.

3. RESULTS {#cam41656-sec-0003}
==========

3.1. Patient cohort characteristics {#cam41656-sec-0004}
-----------------------------------

In total, 495 889 patients diagnosed with nonsmall‐cell lung cancer were extracted. Among all patients, 694 (0.14%) of them died from suicide. Among all patients, 207 306 (41.8%) of them are female while 288 583 (58.2%) of them are male. Among those patients committed suicide, 77 (11.1%) of them are female, and 617 (88.9%) of them are male. In total, 403 288 (81.3%) of them are white, 59 005 (11.9%) of them are black, and 33 596 (6.8%) of them are unknown and other races. As for those suicided patients, 634 (91.4%) of them are white, 25 (3.6%) of them are black, and 35 (5.0%) of them are unknown or other races. In all, 138 210 (27.9%) of them were diagnosed below 60, 237 648 (47.9%) of them were diagnosed between 60 to 75, and 120 031 (24.2%) of them were diagnosed over 75.

3.2. Differences in rates of suicide mortality by decade and state {#cam41656-sec-0005}
------------------------------------------------------------------

The suicide mortality rates between all 3 time intervals were significantly different (before 1993: 0.21%, 1994‐2003: 0.16%, after 2004: 0.09%, overall: 0.14%, *P *\<* *.001) (Table [1](#cam41656-tbl-0001){ref-type="table"}). Patients from Kentucky, Louisiana, New Jersey were not recorded before 1993. When considering differences among different time intervals, California (before 1993: 0.25%, 1994‐2003: 0.18%, after 2004: 0.10%, *P *\<* *.001), Michigan (before 1993: 0.19%, 1994‐2003: 0.12%, after 2004: 0.07%, *P *=* *.001), Washington (before 1993: 0.27%, 1994‐2003:0.19%, after 2004: 0.11%, *P *=* *.010) show significant drop of suicide mortality rate.

###### 

Suicide mortality rates by states and time of diagnosis

  State         Before 1993   SMR (%)   1994‐2003   SMR (%)   After 2004   SMR (%)   Total   SMR (%)   *P*
  ------------- ------------- --------- ----------- --------- ------------ --------- ------- --------- --------
  All states    246           0.21      227         0.16      221          0.09      694     0.14      \<.001
  California    66            0.25      92          0.18      84           0.10      242     0.15      \<.001
  Connecticut   12            0.11      9           0.08      5            0.04      26      0.08      .004
  Georgia       24            0.28      31          0.22      32           0.11      87      0.17      .015
  Hawaii        6             0.14      6           0.20      5            0.12      17      0.15      .100
  Iowa          25            0.15      16          0.17      11           0.10      52      0.14      \<.001
  Kentucky      ---           ---       6           0.09      15           0.07      21      0.08      .058
  Louisiana     ---           ---       5           0.07      14           0.09      19      0.08      .048
  Michigan      48            0.19      17          0.12      10           0.07      75      0.14      \<.001
  New Jersey    ---           ---       7           0.06      16           0.06      23      0.06      .068
  New Mexico    10            0.20      13          0.37      9            0.21      32      0.25      .017
  Utah          13            0.42      6           0.29      6            0.22      25      0.32      .014
  Washington    42            0.27      19          0.19      14           0.11      75      0.20      \<.001

SMR, Suicide mortality rate.
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3.3. Risk factors of suicide mortality in the entire cohort {#cam41656-sec-0006}
-----------------------------------------------------------

Univariate analysis showed that suicide mortality was significantly higher in male patient (*P *\<* *.001), white (*P* \< .001), diagnosed between 60 and 75 (*P *=* *.034), squamous cell carcinoma (*P *=* *.006), surgery (*P *\<* *.001) and without radiation therapy (*P *=* *.018) (Table [2](#cam41656-tbl-0002){ref-type="table"}).

Multivariate logistic regression was then performed including factors significant on univariate analysis. In terms of demographic factors, sex (male vs female: OR 6.22, 95% CI : 4.96‐7.98, *P *\<* *.001), race (white vs black: OR 3.89, 95% CI: 2.66‐5.97, *P *\<* *.001, unknown/others vs black: OR 2.75, 95%CI: 1.65‐4.66, *P *\<* *.001), marital status (unmarried vs married: OR 1.43, 95% CI: 1.22‐1.67, *P *\<* *.001), year at diagnosis (‐1993 vs 2004+: OR 1.83, 95% CI: 1.43‐2.34, *P *\<* *.001,1994‐2003 vs 2004+: OR 1.61, 95% CI: 1.34‐1.95, *P *\<* *.001), age at diagnosis (60‐74 vs \<60: OR 1.24, 95% CI: 1.03‐1.50, *P *=* *.022, \>75 vs \<60: OR 1.32, 95% CI: 1.06‐1.64, *P *=* *.014) were independently associated with higher risk of suicide mortality. As for clinical factors, surgery (Yes vs No: OR: 1.44, 95% CI: 1.19‐1.73, *P *\<* *.001) was relative to higher risk of suicide (Table [2](#cam41656-tbl-0002){ref-type="table"}).

###### 

Results of univariate analysis and multivariable logistic regression for the entire cohort

  Characteristics     Overall   Suicide   SMR (%)   *P* [a](#cam41656-note-0005){ref-type="fn"}   OR          95% CI      *P* [b](#cam41656-note-0006){ref-type="fn"}
  ------------------- --------- --------- --------- --------------------------------------------- ----------- ----------- ---------------------------------------------
  n                   495 889   694       0.14                                                                            
  Sex                                                                                                                     
  Female              207 306   77        0.04      \<.001                                        1.00                    
  Male                288 583   617       0.21      6.22                                          4.92‐7.98   \<.001      
  Race                                                                                                                    
  Black               59 005    25        0.04      \<.001                                        1.00                    
  Unknown/others      33 596    35        0.10      2.75                                          1.65‐4.66   \<.001      
  White               403 288   634       0.16      3.89                                          2.66‐5.97   \<.001      
  Marital                                                                                                                 
  Unmarried           223 335   299       0.13      .319                                          1.43        1.22‐1.67   \<.001
  Married             272 554   395       0.14      1.00                                                                  
  Year at diagnosis                                                                                                       
  2004‐               236 391   221       0.09      \<.001                                        1.00                    
  ‐1993               116 202   246       0.21      1.83                                          1.43‐2.34   \<.001      
  1994‐2003           143 296   227       0.16      1.61                                          1.34‐1.95   \<.001      
  Age at diagnosis                                                                                                        
  \<60                138 210   164       0.12      .034                                          1.00                    
  60‐75               237 648   360       0.15      1.24                                          1.03‐1.50   .024        
  \>75                120 031   170       0.14      1.31                                          1.05‐1.63   .018        
  Site                                                                                                                    
  Upper               250 535   347       0.14      .495                                                                  
  Bronchus/other      107 101   144       0.13                                                                            
  Middle              20 688    24        0.12                                                                            
  Lower               117 565   179       0.15                                                                            
  Grade                                                                                                                   
  I/II                100 566   144       0.14      .175                                                                  
  III/IV              178 591   270       0.15                                                                            
  Unknown             216 732   280       0.13                                                                            
  Histology                                                                                                               
  BAC                 16 275    19        0.12      .006                                          1.00                    
  LCC                 33 119    48        0.14      1.12                                          0.66‐1.96   .679        
  Others              70 826    71        0.10      1.18                                          0.72‐2.03   .533        
  S                   149 388   245       0.16      1.21                                          0.77‐2.01   .431        
  AC                  218 088   296       0.14      1.35                                          0.87‐2.24   .206        
  ASC                 8193      15        0.18      1.45                                          0.72‐2.85   .286        
  Stage                                                                                                                   
  Distant             224 941   246       0.11      \<.001                                        1.00                    
  Localized           73 293    111       0.15      1.15                                          0.89‐1.48   .284        
  Regional            109 710   149       0.14      1.05                                          0.84‐1.30   .684        
  Unstaged            87 945    188       0.21      1.17                                          0.91‐1.52   .219        
  Surgery                                                                                                                 
  No                  364 393   444       0.12      \<.001                                        1.00                    
  Unknown             1081      1         0.09      0.78                                          0.04‐3.45   .801        
  Yes                 130 415   249       0.19      1.44                                          1.19‐1.73   \<.001      
  Months                                                                                                                  
  ≥6 years            46 144    68        0.15      .762                                                                  
  1 year              310 902   436       0.14                                                                            
  2 years             74 528    111       0.15                                                                            
  3 years             33 462    38        0.11                                                                            
  4 years             18 465    26        0.14                                                                            
  5 years             12 388    15        0.12                                                                            
  Radiation                                                                                                               
  No                  265 814   397       0.15      .018                                          1.00                    
  Unknown             2932      8         0.27      1.66                                          0.75‐3.13   .158        
  Yes                 227 143   289       0.13      0.88                                          0.74‐1.03   .109        

AC, Adenocarcinoma; ASC, Adenosquamous carcinoma; BAC, Bronchioloalveolar; CI, confidence interval; LCC, Large cell carcinoma; S, Squamous; SMR, Suicide mortality rate.

*P* value on univariate analysis.

*P* value on logistic regression.
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3.4. Sub‐analysis of patients diagnosed from 2004 to 2013 {#cam41656-sec-0007}
---------------------------------------------------------

This subgroup of patients can better represent the demographic and clinicopathological character of recent patients. So we do the sub‐analysis of patients diagnosed from 2004 to 2013.

Univariate analysis displayed that higher suicide mortality rate was associated with male patients (*P *\<* *.001), white patients (*P *\<* *.001), and patients didn\'t have radiation therapy (*P *=* *.115). Concerning the time after diagnosis, the highest suicide mortality rate was found to be the first year after diagnosis (*P *=* *.008).

Multivariate logistic regression was operated considering factors significant on univariate analysis. In respect of demographic factors, sex (male vs female: OR 7.12, 95% CI: 4.77‐11.12, *P *\<* *.001), race (white vs black: OR 4.76, 95% CI: 2.41‐11.23, *P *\<* *.001, unknown/others vs black: OR 2.46, 95% CI: 0.94‐6.82, *P *=* *.069), marital status (unmarried vs married: OR 1.41, 95% CI:1.08‐1.85, *P *=* *.012) were independently correlated to higher risk of suicide mortality. As for clinical factors, radiation (Yes vs No: OR:0.74, 95% CI: 0.55‐0.99, *P *=* *.046) were relative to higher risk of suicide. Finally, time elapsed from cancer diagnosis was also relative with higher rate of suicide mortality (*P *=* *.008), with the first year of diagnosis taking the highest rate (OR 4.79, 95% CI: 1.93‐15.97, *P *=* *.003), followed by the second year (OR 4.31, 95% CI: 1.68‐14.60, *P *=* *.007) (Table [3](#cam41656-tbl-0003){ref-type="table"}).

###### 

Results of univariate analysis and multivariable logistic regression for patients diagnosed 2004‐2013

  Characteristics    Overall   Suicide   SMR (%)   *P* [a](#cam41656-note-0008){ref-type="fn"}   OR           95% CI       *P* [b](#cam41656-note-0009){ref-type="fn"}
  ------------------ --------- --------- --------- --------------------------------------------- ------------ ------------ ---------------------------------------------
  n                  236 391   221       0.09                                                                              
  Sex                                                                                                                      
  Male               128 081   196       0.15      \<.001                                        7.12         4.77‐11.12   \<.001
  Female             108 310   25        0.02      1.00                                                                    
  Race (%)                                                                                                                 
  Black              28 908    7         0.02      \<.001                                        1.00                      
  Unknown/others     18 072    10        0.06      2.46                                          0.94‐6.82    .069         
  White              189 411   204       0.11      4.76                                          2.41‐11.23   \<.001       
  Marital                                                                                                                  
  Unmarried          115 326   109       0.09      .927                                          1.41         1.08‐1.85    .012
  Married            121 065   112       0.09      1.00                                                                    
  Age at diagnosis                                                                                                         
  \<60               61 248    48        0.08      .221                                          1.00                      
  60‐75              109 508   102       0.09      1.08                                          0.77‐1.54    .676         
  \>75               65 635    71        0.11      1.22                                          0.84‐1.79    .295         
  Site                                                                                                                     
  Upper              121 665   108       0.09      .328                                          1.00                      
  Bronchus/other     45 091    39        0.09      0.92                                          0.62‐1.33    .66          
  Middle             10 070    7         0.07      0.84                                          0.35‐1.67    .653         
  Lower              59 565    67        0.11      1.24                                          0.91‐1.68    .163         
  Grade                                                                                                                    
  I/II               50 487    41        0.08      .468                                          1.00                      
  III/IV             72 850    75        0.10      1.22                                          0.83‐1.82    .316         
  Unknown            113 054   105       0.09      1.22                                          0.82‐1.83    .338         
  Histology                                                                                                                
  BAC                5805      1         0.02      .292                                                                    
  LCC                6269      6         0.10                                                                              
  Others             49 618    43        0.09                                                                              
  S                  61 110    58        0.09                                                                              
  AC                 110 006   107       0.10                                                                              
  ASC                3583      6         0.17                                                                              
  Stage                                                                                                                    
  Distant            132 310   122       0.09      .977                                          1.00                      
  Localized          41 332    40        0.10                                                    1.24         0.8‐1.89     .321
  Regional           56 549    54        0.10                                                    1.10         0.76‐1.56    .608
  Unstaged           6200      5         0.08                                                    0.86         0.3‐1.92     .751
  Surgery                                                                                                                  
  No                 184 415   170       0.09      .761                                          1.00                      
  Unknown            560       1         0.18      2.06                                          0.12‐9.27    .475         
  Yes                51 416    50        0.10      1.34                                          0.88‐2.04    .168         
  Months                                                                                                                   
  ≥6 years           15 970    4         0.03      .008                                          1.00                      
  1 year             147 889   159       0.11      4.79                                          1.93‐15.97   .003         
  2 years            37 135    35        0.09      4.31                                          1.68‐14.6    .007         
  3 years            18 001    13        0.07      3.24                                          1.14‐11.58   .041         
  4 years            10 353    8         0.08      3.32                                          1.04‐12.46   .051         
  5 years            7043      2         0.03      1.18                                          0.16‐6.06    .848         
  Radiation                                                                                                                
  No                 136 621   143       0.10      .115                                          1.00                      
  Unknown            1329      1         0.08      0.63                                          0.04‐2.83    .65          
  Yes                98 441    77        0.08      0.74                                          0.55‐0.99    .046         

AC: Adenocarcinoma; ASC: Adenosquamous carcinoma; BAC: Bronchioloalveolar; CI: confidence interval; LCC: Large cell carcinoma; S: Squamous; SMR: Suicide mortality rate.

*P* value on univariate analysis.

*P* value on logistic regression.
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4. DISCUSSION {#cam41656-sec-0008}
=============

Our study observed significant improvement in suicide prevention among NSCLC patients in US over past decades. Urban et al[9](#cam41656-bib-0009){ref-type="ref"} found that suicide has not changed significantly decreased in lung cancer over time. However, in contrast to rising suicide rate of US general population, the suicide mortality rate of NSCLC patients has decreased considerably over past decades, which is consistent with previous study about suicide trend among cancer patients.[12](#cam41656-bib-0012){ref-type="ref"}, [13](#cam41656-bib-0013){ref-type="ref"}, [14](#cam41656-bib-0014){ref-type="ref"} This result may be associated with relatively better prognosis of NSCLC, because of early screening test for lung cancer and significant advances in treatment, such as chemotherapy and targeted therapy.[15](#cam41656-bib-0015){ref-type="ref"}, [16](#cam41656-bib-0016){ref-type="ref"}, [17](#cam41656-bib-0017){ref-type="ref"}

Demographic characteristics associated with an increased rate of suicide in the NSCLC patients, such as older age, male sex, race were similar to those in general population.[18](#cam41656-bib-0018){ref-type="ref"} Earlier research showed that older people tend to commit complete suicide among general population.[19](#cam41656-bib-0019){ref-type="ref"}, [20](#cam41656-bib-0020){ref-type="ref"} Older patients with cancer are also high‐risk group, which is consistent with our research.[21](#cam41656-bib-0021){ref-type="ref"}, [22](#cam41656-bib-0022){ref-type="ref"}, [23](#cam41656-bib-0023){ref-type="ref"} Older patients usually encountered with greater disease burden, and social psychological pressure. Higher suicide rate of older NSCLC patients may be related to pressure and depression.[20](#cam41656-bib-0020){ref-type="ref"} Another possible reason is that, they hold the rational will of ending their life at the right time.[24](#cam41656-bib-0024){ref-type="ref"} Male sex is a risk factor of suicide in NSCLC patients, and it is accordant with trends in general population and those with other cancer.[2](#cam41656-bib-0002){ref-type="ref"}, [25](#cam41656-bib-0025){ref-type="ref"} Although depression seemed to be higher in female patients with NSCLC, male patients are more likely to succeed in ending their own life.[26](#cam41656-bib-0026){ref-type="ref"}, [27](#cam41656-bib-0027){ref-type="ref"} However, the incidence of female suicidal behavior in NSCLC patients may be underrepresented, because failed suicide attempts were not recorded in the SEER database.[22](#cam41656-bib-0022){ref-type="ref"} Race has a significant impact on suicidal ideation. The risk of dying from suicide was more than double for the white NSCLC patients than for the black patients.[28](#cam41656-bib-0028){ref-type="ref"} The reason is for higher suicide rate in white patients with NSCLC is still unknown, and hopelessness in those patients is likely to associate with suicidal behavior.[29](#cam41656-bib-0029){ref-type="ref"} In addition, unmarried NSCLC patients are easier exposed to suicide attempts. Married patients have a greater socioeconomic status than unmarried.[30](#cam41656-bib-0030){ref-type="ref"}, [31](#cam41656-bib-0031){ref-type="ref"} Many cancer research studies have reported a poor prognosis in unmarried patients.[32](#cam41656-bib-0032){ref-type="ref"}, [33](#cam41656-bib-0033){ref-type="ref"}, [34](#cam41656-bib-0034){ref-type="ref"}

Interestingly, characteristics of NSCLC seems to be not relevant to suicide of patients, which is controversial with former analysis.[9](#cam41656-bib-0009){ref-type="ref"} In patients diagnosed between 1973 and 2013, clinical characteristics such as primary site, histologic type, historic stage have no significant influence on suicide. The same as those diagnosed recently. A possible reason is that multiple primary tumor may interfere with the result. In our study, patients with multiple primary tumor were excluded to prevent interference of other tumors. Another possible reason is that the prognosis of patients with advanced NSCLC is poor, they may die from the disease itself rather than other causes. Patients diagnosed between 1973 and 2013 who undergo treatment like surgery are more likely to suicide. This is also different from previous research.[9](#cam41656-bib-0009){ref-type="ref"} It can be explained by debility and loss of autonomy brought by the curative surgery toward NSCLC.[35](#cam41656-bib-0035){ref-type="ref"}

When considering patients diagnosed between 1973 and 2013, Suicide mortality rate (SMR) is not significantly associated with time after diagnosed. But SMR is observed to be higher within the first year of NSCLC diagnosis among patients diagnosed between 2004 and 2013. It has been reported that cancer patients were at high risk of suicide within the first year of diagnosis and associated demographic and clinical factors were analyzed.[36](#cam41656-bib-0036){ref-type="ref"} The different result can be possibly explained by the improvement of life quality of long‐term survivor of NSCLC patients, and the major reason for suicidal behavior of recent NSCLC patients is possibly shock of cancer diagnosis.[37](#cam41656-bib-0037){ref-type="ref"}, [38](#cam41656-bib-0038){ref-type="ref"}

While the demographic risk factors of cancer‐related suicide are focused on, psychological and social risk factors are frequently missed. Suicide is a complicated phenomenon that biological, psychological and social risk factors would interact and influence on it. Cancer diagnosis may lead to demoralization of NSCLC patients, such as hopelessness and helplessness, which can lead to suicidal ideation.[39](#cam41656-bib-0039){ref-type="ref"} Poor consequences of cancer treatment may bring physical and mental pain to NSCLC patients.[40](#cam41656-bib-0040){ref-type="ref"} It has been reported that cancer patients with low socioeconomic status and family support are more likely to suicide.[41](#cam41656-bib-0041){ref-type="ref"} The National Comprehensive Cancer Network provides a distress management guideline that recommends screening all patients for distress.[42](#cam41656-bib-0042){ref-type="ref"} Our findings may assist oncologists to effectively identify those NSCLC patients at higher risk of suicide, specifically for older, white, unmarried male patients with surgery. For those NSCLC patients with high risk of suicide, we should pay more attention, because appropriate psychosocial interventions have a positive impact on quality of life.[43](#cam41656-bib-0043){ref-type="ref"} To reduce cancer‐related suicide, patients' understanding of cancer diagnosis and treatment options should be ensured.[44](#cam41656-bib-0044){ref-type="ref"} Besides, promoting family communication combine with encouraging self‐determination and participation in treatment can mitigate social risk of suicide.[44](#cam41656-bib-0044){ref-type="ref"}, [45](#cam41656-bib-0045){ref-type="ref"}

There are some limitations in our study. Suicide is a complicated phenomenon affected by factors such as economic level and education level. These factors are not included in SEER database. Additionally, SEER database only contains data of US patients, so our study is limited to US patients, and research over the world is still needed. Moreover, details of treatment to NSCLC were not taken in, and we only know whether patients have undergone surgery and radiation or not. Details of treatment such as the time after surgery and chemotherapy may be associated with suicide of cancer patient.[3](#cam41656-bib-0003){ref-type="ref"} Furthermore, our study can\'t obtain suicide attempts data of NSCLC patients, and patients potential to suicide were likely to be underestimated.

5. CONCLUSIONS {#cam41656-sec-0009}
==============

In summary, our study observed a significant decrease in suicide mortality among NSCLC patients in US over past decades. Older age, male sex, unmarried status, and surgery were risk factors of committing suicide. Grade, stage, histologic type and primary site of NSCLC appear not relate to suicide. It can help clinicians identified these NSCLC patients for better support and suicide prevention. Further studies are still needed.
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